CAMURUS AB CAMURUS ORD SHS (0RD1.L) Financials
0RD1.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 1.8 billion | 353.4 million |
2023-06-30 | 1.8 billion | 391.7 million |
2023-03-31 | 1.3 billion | 288.6 million |
0RD1.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 484.3 million | 17.8 million |
2023-06-30 | 62.4 million | 19.8 million |
2023-03-31 | 23.3 million | 5.5 million |
0RD1.L Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -15.2 million |
2023-09-30 | 86.4 million |
2023-06-30 | 301.4 million |
2023-03-31 | 58.8 million |
0RD1.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 1.2 billion | - | - |
2023-06-30 | 654.1 million | - | - |
2023-03-31 | 585.8 million | - | - |
0RD1.L Shares Outstanding
0RD1.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 1.4 million | 147.7 million | 10.4 million | 94.4 million |
2023-06-30 | 4.5 million | 160.6 million | 12.1 million | 94.0 million |
2023-03-31 | 928000 | 99.3 million | 9.3 million | 75.6 million |
0RD1.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 384.0 million | 32.0 million |
2023-06-30 | 674.3 million | 29.0 million |
2023-03-31 | 284.0 million | 28.8 million |
0RD1.L
Price: SEK554.50
52 week price:
Earnings Per Share: -1.27 SEK
P/E Ratio: -355.10
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 234.4 million